Group by:
Date |
Item TypeArticle
Excessive hypertension and end-organ damage in a transgenic mouse line carrying the rat angiotensinogen gene.
Xu, P. and Wang, Y. and Sterner-Kock, A. and Bader, M. and Schultheiss, H.P. and Walther, T.
Journal of Cardiovascular Pharmacology 53
(1): 38-43.
January 2009
The endothelium-dependent vasodilator effect of the nonpeptide Ang(1-7) mimic AVE 0991 is abolished in the aorta of Mas-knockout mice.
Lemos, V.S. and Silva, D.M. and Walther, T. and Alenina, N. and Bader, M. and Santos, R.A.
Journal of Cardiovascular Pharmacology 46
(3): 274-279.
1 September 2005
Fluorescence resonance energy transfer analysis reveals the existence of endothelin-A and endothelin-B receptor homodimers.
Gregan, B. and Schaefer, M. and Rosenthal, W. and Oksche, A.
Journal of Cardiovascular Pharmacology 44
(Suppl 1): S30-S33.
November 2004
Effects of combined therapy with clopidogrel and acetylsalicylic acid on platelet glycoprotein expression and aggregation.
Dorr, G. and Schmidt, G. and Graefe, M. and Regitz-Zagrosek, V. and Fleck, E.
Journal of Cardiovascular Pharmacology 39
: 523-532.
1 April 2002
Efficacy of angiotensin II type 1 receptor blockade on reperfusion-induced arrhythmias and mortality early after myocardial infarction is increased in transgenic rats with cardiac angiotensin II type 1 overexpression.
de Boer, R.A. and van Geel, P.P. and Pinto, Y.M. and Suurmeijer, A.J.H. and Crijns, H.J.G.M. and van Gilst, W.H. and van Veldhuisen, D.J.
Journal of Cardiovascular Pharmacology 39
(4): 610-619.
April 2002
Molecular interactions of vasoactive systems in cardiovascular damage.
Bader, M.
Journal of Cardiovascular Pharmacology 38
(2): S7-S9.
1 January 2001
Evidence for downregulation of the endothelin-B-receptor by the use of fluorescent endothelin-1 and a fusion protein consisting of the endothelin-B-receptor and the green fluorescent protein.
Oksche, A. and Boese, G. and Horstmeyer, A. and Papsdorf, G. and Furkert, J. and Beyermann, M. and Bienert, M. and Rosenthal, W.
Journal of Cardiovascular Pharmacology 36
(5 Suppl 1): S44-S47.
November 2000
Insulin resistance in chronic heart failure.
Coats, A.J. and Anker, S.D. and Anker, S.
Journal of Cardiovascular Pharmacology 35
: S9-14.
1 January 2000
Angiotensin II AT1-receptor blockade inhibits monocyte activation and adherence in transgenic (mRen2)27 rats.
Strawn, W.B. and Gallagher, P.E. and Tallant, E.A. and Ganten, D. and Ferrario, C.M.
Journal of Cardiovascular Pharmacology 33
: 341-351.
1 March 1999
Microalbuminuria as a predictive factor for cardiovascular events.
Luft, F.C. and Agrawal, B.
Journal of Cardiovascular Pharmacology 33 Suppl. 1; discussion S41-S43
: S11-S15.
15 January 1999
Dissociation of the effects of forskolin and dibutyryl cAMP on force of contraction and phospholamban phosphorylation in human heart failure.
Neumann, J. and Bartel, S. and Eschenhagen, T. and Haverich, A. and Hirt, S. and Karczewski, P. and Krause, E.G. and Schmitz, W. and Scholz, H. and Stein, B. and Thoenes, M.
Journal of Cardiovascular Pharmacology 33
: 157-162.
1 January 1999
Interaction of the renin-angiotensin system and the endothelin system in cardiac hypertrophy.
Stula, M. and Pinto, Y.M. and Gschwend, S. and Teisman, A.C. and van Gilst, W.H. and Bohm, M. and Dietz, R. and Paul, M.
Journal of Cardiovascular Pharmacology 31 Suppl. 1
: S403-S405.
1 January 1998
Transcriptional regulation of endothelin-1 by erythropoietin in endothelial cells.
Liefeldt, L. and Schmidt-Ott, K.M. and Orzechowski, H.D. and Distler, A. and Paul, M.
Journal of Cardiovascular Pharmacology 31
(Suppl 1): S464-S466.
1998
Single-cell characterization of endothelin system gene expression in the cerebellum in situ.
Schmidt-Ott, K.M. and Tuschick, S. and Kirchhoff, F. and Verkhratsky, A. and Liefeldt, L. and Kettenmann, H. and Paul, M.
Journal of Cardiovascular Pharmacology 31
(Suppl 1): S364-S366.
1998
Improvement of vagal tone by ACE inhibition: a mechanism of cardioprotection in patients with mild-to- moderate heart failure.
Osterziel, K.J. and Dietz, R.
Journal of Cardiovascular Pharmacology 27 Suppl.
: S25-S30.
1 January 1996
Regulation of the endothelin system in transgenic rats expressing the human endothelin-2 gene.
Liefeldt, L. and Boecker, W. and Schoenfelder, G. and Zintz, M. and Paul, M.
Journal of Cardiovascular Pharmacology 26
(Suppl:3): S32-S33.
1 January 1995
Plasma endothelin-1 levels in human lung transplant recipients.
Shennib, H. and Serrick, C. and Saleh, D. and Reis, A. and Stewart, D.J. and Giaid, A.
Journal of Cardiovascular Pharmacology 26 Suppl 3
: S516-S518.
1 January 1995
Cardiac norepinephrine, beta-adrenoceptors, and Gialpha- proteins in prehypertensive and hypertensive spontaneously hypertensive rats.
Boehm, M. and Castellano, M. and Paul, M. and Erdmann, E.
Journal of Cardiovascular Pharmacology 23
: 980-987.
1 January 1994
The renin-angiotensin system in the heart and vascular wall: New therapeutic aspects.
Falkenhahn, M. and Gohlke, P. and Paul, M. and Stoll, M. and Unger, T.
Journal of Cardiovascular Pharmacology 24
: S6-S13.
1 January 1994
Genetics of primary hypertension.
Ganten, D. and Schmidt, S. and Paul, M.
Journal of Cardiovascular Pharmacology 24
: S45-S50.
1 January 1994
Effects of enalaprilat on circadian profiles in blood pressure and heart rate of spontaneously and transgenic hypertensive rats.
Lemmer, B. and Witte, K. and Makabe, T. and Ganten, D. and Mattes, A.
Journal of Cardiovascular Pharmacology 23
: 311-314.
1 January 1994
Converting enzyme inhibition improves congestion and survival in hypertensive rats with high-output heart failure.
Nishimura, H. and Oka, T. and Ueyama, M. and Kubota, J. and Kawamura, K.
Journal of Cardiovascular Pharmacology 23
: 149-154.
1 January 1994
Interactions between the renin-angiotensin system and the parasympathetic nervous system in heart failure.
Osterziel, K.J. and Haenlein, D. and Dietz, R.
Journal of Cardiovascular Pharmacology 24 Suppl. 2
: S70-S74.
1 January 1994
The transition from experimental to clinical pharmacology: the renin-angiotensin paradigm.
Ganten, D.
Journal of Cardiovascular Pharmacology 22 (Suppl.1)
: S14-S29.
1 January 1993
Torasemide in the treatment of arterial hypertension.
Luft, F.C.
Journal of Cardiovascular Pharmacology 22 Suppl. 3
: S32-S39.
1 January 1993
The brain renin-angiotensin system - localization and general significance.
Bunnemann, B. and Fuxe, K. and Ganten, D.
Journal of Cardiovascular Pharmacology 19
(Suppl 6): S51-S62.
1 January 1992
Left ventricular remodeling after myocardial infarction - does the cardiac renin angiotensin system play a role?
Lindpaintner, K. and Niedermaier, N. and Drexler, H. and Ganten, D.
Journal of Cardiovascular Pharmacology 20
: S41-S47.
1 January 1992
The molecular basis of cardiovascular hypertrophy: the role of the renin angiotensin system.
Paul, M. and Ganten, D.
Journal of Cardiovascular Pharmacology 19
(Suppl 5): S51-S58.
1 January 1992
The effect of the partial beta-1-adrenoceptor agonist xamoterol on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy.
Thierfelder, L. and Holubarsch, C. and Hasenfuss, G. and Heiss, H.W. and Just, H.
Journal of Cardiovascular Pharmacology 17
: 593-599.
1 April 1991
Improvement of diastolic filling in hypertensive patients treated with cilazapril.
Haberbosch, W. and De Simone, R. and Dietz, R. and Waas, W. and Tillmanns, H. and Kuebler, W.
Journal of Cardiovascular Pharmacology 17
(Suppl 2): S159-S162.
1 January 1991
Editorial
The Gross, Franz Hypertension Symposium Series - Introduction.
Ganten, D.
Journal of Cardiovascular Pharmacology 20
: 5-6.
1 January 1992
This list was generated on Thu Apr 25 02:34:12 2024 CEST.